ACCC joined nearly 70 provider and patient organizations in urging Congress to increase funding for the Lung Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) in the Fiscal Year 2023 Defense appropriations bill. The letter asks Congress to increase funding for this program from $20 to $60 million to approximate the level of support necessary to fund high-quality research applications and to ensure that funding is commensurate with the impact of deaths attributable to lung cancer among Veterans Health Administration patients.
